Covenant Asset Management’s Celgene Corp CELG Stock Holding History

Covenant Asset Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-17,755	Closed	-$1.85M	–	166
2017 Q4	$1.85M	Sell	17,755 -11,311	-39%	-$1.28M	1.08%	32
2017 Q3	$4.24M	Buy	29,066 +13	+0%	+$1.77K	2.59%	4
2017 Q2	$3.77M	Sell	29,053 -828	-3%	-$101K	2.41%	6
2017 Q1	$3.72M	Sell	29,881 -4,438	-13%	-$531K	2.51%	5
2016 Q4	$3.97M	Buy	+34,319	New	+$3.82M	2.67%	3

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Covenant Asset Management's CELG Position: Q1 2018 in Review

Covenant Asset Management sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 17,755 shares — an estimated $1.85M sold.

Covenant Asset Management first reported a position in CELG in Q4 2016 and held it in 5 quarters. The position peaked at $4.24M in Q3 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

Covenant Asset Management reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
Covenant Asset Management sold 17,755 Celgene Corp shares in Q1 2018, an estimated $1.85M.
Covenant Asset Management first reported a position in Celgene Corp in Q4 2016 and held it in 5 quarters.
Covenant Asset Management's Celgene Corp position peaked at $4.24M in Q3 2017.
1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Covenant Asset Management's 13F filing for Q1 2018, filed 4 May 2018.